Cargando…
Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence
Atypical haemolytic uraemic syndrome (aHUS) is a rare disease characterized by thrombocytopenia, microangiopathic haemolytic anaemia and renal impairment. Mutations in genes encoding inhibitors of the alternative pathway of the complement system are involved in ∼50% of the cases. Thrombomodulin (THB...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440472/ https://www.ncbi.nlm.nih.gov/pubmed/26034596 http://dx.doi.org/10.1093/ckj/sfv025 |
_version_ | 1782372646530318336 |
---|---|
author | Caroti, Leonardo Di Maria, Lorenzo Carta, Paolo Moscarelli, Luciano Cirami, Calogero Minetti, Enrico Eugenio |
author_facet | Caroti, Leonardo Di Maria, Lorenzo Carta, Paolo Moscarelli, Luciano Cirami, Calogero Minetti, Enrico Eugenio |
author_sort | Caroti, Leonardo |
collection | PubMed |
description | Atypical haemolytic uraemic syndrome (aHUS) is a rare disease characterized by thrombocytopenia, microangiopathic haemolytic anaemia and renal impairment. Mutations in genes encoding inhibitors of the alternative pathway of the complement system are involved in ∼50% of the cases. Thrombomodulin (THBD) gene mutations occur in ∼3–5% of the cases. The risk of aHUS recurrence after kidney transplantation depends on the complement abnormality involved. In all three cases of THBD mutation reported to date, aHUS recurred after kidney transplantation (KT) with early graft loss. No data exist about therapeutic approaches before kidney transplantation to reduce the risk of recurrence in patients carrying this mutation. Favourable data on the use of eculizumab have been reported, in terms of plasmatherapy withdrawal and renal function recovery in aHUS recurrence after KT. To our knowledge, this case report presents the first case of successful kidney transplantation in a patient with aHUS due to THBD mutation who was treated with a single plasma-exchange immediately before surgery without recurrence of the disease 12 months after transplantation. |
format | Online Article Text |
id | pubmed-4440472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44404722015-06-01 Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence Caroti, Leonardo Di Maria, Lorenzo Carta, Paolo Moscarelli, Luciano Cirami, Calogero Minetti, Enrico Eugenio Clin Kidney J Contents Atypical haemolytic uraemic syndrome (aHUS) is a rare disease characterized by thrombocytopenia, microangiopathic haemolytic anaemia and renal impairment. Mutations in genes encoding inhibitors of the alternative pathway of the complement system are involved in ∼50% of the cases. Thrombomodulin (THBD) gene mutations occur in ∼3–5% of the cases. The risk of aHUS recurrence after kidney transplantation depends on the complement abnormality involved. In all three cases of THBD mutation reported to date, aHUS recurred after kidney transplantation (KT) with early graft loss. No data exist about therapeutic approaches before kidney transplantation to reduce the risk of recurrence in patients carrying this mutation. Favourable data on the use of eculizumab have been reported, in terms of plasmatherapy withdrawal and renal function recovery in aHUS recurrence after KT. To our knowledge, this case report presents the first case of successful kidney transplantation in a patient with aHUS due to THBD mutation who was treated with a single plasma-exchange immediately before surgery without recurrence of the disease 12 months after transplantation. Oxford University Press 2015-06 2015-04-27 /pmc/articles/PMC4440472/ /pubmed/26034596 http://dx.doi.org/10.1093/ckj/sfv025 Text en © The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Contents Caroti, Leonardo Di Maria, Lorenzo Carta, Paolo Moscarelli, Luciano Cirami, Calogero Minetti, Enrico Eugenio Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence |
title | Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence |
title_full | Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence |
title_fullStr | Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence |
title_full_unstemmed | Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence |
title_short | Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence |
title_sort | posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence |
topic | Contents |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440472/ https://www.ncbi.nlm.nih.gov/pubmed/26034596 http://dx.doi.org/10.1093/ckj/sfv025 |
work_keys_str_mv | AT carotileonardo posttransplantoutcomeofatypicalhaemolyticuraemicsyndromeinapatientwiththrombomodulinmutationacasewithoutrecurrence AT dimarialorenzo posttransplantoutcomeofatypicalhaemolyticuraemicsyndromeinapatientwiththrombomodulinmutationacasewithoutrecurrence AT cartapaolo posttransplantoutcomeofatypicalhaemolyticuraemicsyndromeinapatientwiththrombomodulinmutationacasewithoutrecurrence AT moscarelliluciano posttransplantoutcomeofatypicalhaemolyticuraemicsyndromeinapatientwiththrombomodulinmutationacasewithoutrecurrence AT ciramicalogero posttransplantoutcomeofatypicalhaemolyticuraemicsyndromeinapatientwiththrombomodulinmutationacasewithoutrecurrence AT minettienricoeugenio posttransplantoutcomeofatypicalhaemolyticuraemicsyndromeinapatientwiththrombomodulinmutationacasewithoutrecurrence |